Beta-2 Microglobulin (B2M)
| Product Name | Beta-2 Microglobulin |
| Source | Recombinant |
| Catalogue Number | 126-14 |
| Form | Lyophilized |
| Purity | > 95% (HPLC) |
| Expression System | E.coli |
| Protein | Report mg protein/vial (E0.1%280nm = 1.47) |
| Sequence | Full length (B2MG_Human 21-119) |
| Formulation | Powder lyophilized from sodium citrate, pH 7.0. |
| Reconstitution | Reconstitute with phosphate buffered saline, pH 7.4 with 0.05% sodium azide. |
| Related Products | GB2-80A - Goat anti-Human B2M polyclonal antibody 126-12 - B2M antigen from human urine - Liquid 431-11 - Myoglobin antigen from human heart |
| Storage | -20°C |
| Recertification | 5 years |
| Synonyms | r-hB2M, r-B2M |
| Molecular Weight | 11,731 |
Lee Biosolutions is the leading producer and supplier of recombinant Beta-2 Microglobulin (B2M) for use in medical research and manufacturing of clinical diagnostic assays.
Custom preparations, technical support, bulk quantities and aliquoting available, email Info@leebio.com for more details.
Serum beta-2 Microglobulin, an endogenous marker for renal function, has been shown to be an independent predictor of mortality in older adults.
The characteristics of B2M make it useful as a tumor marker for some blood cell cancers, for detecting kidney damage, and for distinguishing between glomerular and tubular disorders of the kidney. It is not diagnostic for a specific disease, but it gives the doctor additional information about someone's likely prognosis and about the health of their kidneys.
Lee Biosolutions, Inc
